Kathleen R. Cho | |
|---|---|
| Born | Los Alamos, New Mexico, U.S. |
| Spouse | Eric Fearon |
| Academic background | |
| Education | BA, 1980, Yale University MD, 1984, Vanderbilt University School of Medicine |
| Academic work | |
| Institutions | Michigan Medicine Johns Hopkins University |
Kathleen R. Cho is an American gynecological surgical pathologist. She is a Professor of Pathology and Internal Medicine at Michigan Medicine.
Cho was born in Los Alamos,New Mexico,and grew up in Rockville,Maryland. [1] Cho received her Bachelor of Arts degree from Yale University in 1980 and her medical degree from Vanderbilt University School of Medicine in 1984. Following this,she completed her Anatomic Pathology residency at the Johns Hopkins Hospital and served as Chief Resident in her final year. During her residency,she simultaneously served as a Clinical Fellow in the Johns Hopkins Department of Pathology and Research Fellow in the Molecular Genetics Laboratory of the Johns Hopkins Oncology Center. [2]
Following her residency,Cho became an Instructor in the Department of Pathology at Johns Hopkins University before being appointed to the rank of assistant professor in the Departments of Pathology,Oncology,and Gynecology and Obstetrics in 1991. She remained with Johns Hopkins until 1998 when she accepted an associate professor position at the University of Michigan. [2] As a result of her research in molecular biology,she was elected a Fellow of the American Society for Clinical Investigation in 2000. [3] Following her promotion to Full professor with tenure in 2002, [4] Cho's laboratory developed a mouse model to research ovarian endometrioid adenocarcinoma. [5]
From 2013 to 2014,Cho served as Interim Chair of the University of Michigan's Department of Pathology. [6] Following this,she was elected a member of the National Academy of Medicine for both her diagnostic expertise and laboratory research in gynecological cancer. [7] In 2017,her research team used genetically modified mice to mimic tumors that closely resembled human high-grade serous carcinomas. [6]
In January 2019,Cho received a five-year R01 grant from the National Institutes of Health to continue her work in ovarian cancer research. [8]
Cho and her husband,Eric Fearon,have two daughters together. In her free time,she enjoys watching basketball and cooking. [1]

The Johns Hopkins University School of Medicine (JHUSOM) is the medical school of Johns Hopkins University,a private research university in Baltimore,Maryland. Founded in 1893,the School of Medicine shares a campus with Johns Hopkins Hospital and Johns Hopkins Children's Center,established in 1889.
Jonathan S. Berek, MD MMS is the Laurie Kraus Lacob Professor at the Stanford University School of Medicine,Director of the Stanford Women's Cancer Center,and Senior Advisor,Stanford Cancer Institute. He is a recent past Fellow in the Stanford Distinguished Careers Institute.
Kelly J. Manahan is an American gynecologist who is the current Chair of Obstetrics and Gynecology at the University of Toledo College of Medicine and Life Sciences in Toledo,Ohio.
George Dewey Wilbanks Jr. was an American cancer researcher,surgeon,and professor of obstetrics and gynecology. He was best known for his research in cervical cancer and was responsible for early work identifying the human papillomavirus and its relationship to the development of cancer,eventually leading to the development of the herpes vaccine Gardasil.
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
Christine M. Lovly is an associate professor of medicine at Vanderbilt University. Her research involves the development of novel treatment strategies for ALK positive lung cancer.

Christine Campo Alewine is an American oncologist and biologist researching immunotoxin therapeutics in pancreatic cancer. She is an investigator at the National Cancer Institute.
Christina Messineo Annunziata is an American medical oncologist researching molecular signal transduction in ovarian cancer. She is an investigator in the National Cancer Institute's women's malignancies branch and head of the translational genomics section.
Mary Armanios is Professor of Oncology,Genetic Medicine,Pathology and Molecular Biology,and Genetics at Johns Hopkins University School of Medicine and the Director of the Telomere Center at Johns Hopkins University. Her research focuses on the role of telomeres in disease.
Dineo Khabele is an American obstetrician who is Mitchell and Elaine Yanow Professor of Obstetrics and Gynecology at Washington University School of Medicine. In 2019 Khabele was elected to the American Society for Clinical Investigation.
Allison Walsh Kurian is an American medical oncologist. She is a Professor of Medicine and Epidemiology &Population Health at Stanford University and an oncologist at the Stanford Cancer Institute.
Jung-Min Lee is a South Korean-American medical oncologist and physician-scientist focused on the early clinical drug development and translational studies of targeted agents in BRCA mutation-associated breast or ovarian cancer,high-grade epithelial ovarian cancer,and triple-negative breast cancer. She is a NIH Lasker Clinical Research Scholar and principal investigator in the Women's Malignancies Branch at the National Cancer Institute.
Ernst Robert Lengyel is an American gynecologic oncologist. Lengyel is the Arthur L. and Lee G. Herbst Professor of Obstetrics and Gynecology at the University of Chicago. Lengyel directs the Ovarian Cancer Research Laboratory,a translational research laboratory focused on understanding ovarian cancer metastasis and on developing and testing new treatments for ovarian cancer. In this role,Lengyel and his research team began to investigate the role of the fallopian tube in ovarian cancer as the cells more closely resemble those in the fallopian tube rather than the ovary.
Lori Jo Pierce is an American radiation oncologist and 57th President of the American Society of Clinical Oncology. She is a Full Professor and Vice Provost for Academic and Faculty Affairs at the University of Michigan. Her research focuses on the use of radiotherapy in the multi-modality treatment of breast cancer,with emphasis on intensity modulated radiotherapy in node positive breast cancer,the use of radiosensitizing agents,and the outcomes of women treated with radiation for breast cancer who are carriers of a BRCA1/2 breast cancer susceptibility gene.
Bradley J. Monk is an American gynecologic oncologist,academician and researcher. He is a professor on the Clinical Scholar Track in the Department of Obstetrics and Gynecology at the University of Arizona College of Medicine in Phoenix,Arizona,as well as at the Creighton University School of Medicine in Omaha,Nebraska. He also serves as Director of the Division of Gynecologic Oncology at the St. Joseph's Hospital and Medical Center in Phoenix.
Beth Young Karlan is an American gynecologic oncologist. In 2008,she was named editor-in-chief of the medical journals Gynecologic Oncology and Gynecologic Oncology Reports. In 2012,Karlan was appointed by the White House to serve on the National Cancer Advisory Board,and in 2015,she was elected to the National Academy of Medicine.
Eric Reese Fearon is an American oncologist. He is the Emanuel N. Maisel Professor of Oncology at the University of Michigan and director of the University of Michigan Rogel Cancer Center.
Carol L. Brown is the Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering Cancer Center and a professor at Weill Cornell Medical College. She is a surgeon known for her work on gynecological cancers.
W. Kimryn Rathmell is an American physician-scientist whose work focuses on the research and treatment of patients with kidney cancers. She is the 17th Director of the National Cancer Institute,having previously served as the Hugh Jackson Morgan Professor and Chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC),and Physician-in-Chief for Vanderbilt University Adult Hospital and Clinics in Nashville,Tennessee. On November 17,2023,Rathmell was nominated by President Biden as the next Director of the National Cancer Institute and she assumed office on December 18,2023.
Andrea Lynn Richardson is an American pathologist and physician-scientist specialized in the molecular pathology of breast cancer. She is the Peter and Judy Kovler Professor in Breast Cancer Research and an associate professor of pathology and oncology at the Johns Hopkins School of Medicine. Richardson runs a clinic at the Sibley Memorial Hospital.